Nanobiotix Engages with Investors at November Conferences

Nanobiotix, a biotechnology company focusing on nanotherapeutic solutions for cancer and other diseases, is set to participate in two major investor conferences in November. The company aims to expand its outreach to potential investors at these events.

The first event, the Jefferies Global Healthcare Conference, will take place in London on November 16, 2026. During this conference, both Laurent Levy, the CEO, and Arnd Christ, the CFO, will present the company’s innovative approaches and strategic vision.

Following this, Nanobiotix will also be present at the UBS Global Biopharma Conference in London on November 17, 2026. This engagement underscores the company's proactive strategy to strengthen investor relations and share advancements in its clinical-stage nanotechnology platforms aimed at enhancing treatment possibilities.